Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMPH.L Regulatory News (MPH)

  • There is currently no data for MPH

Interim Management Statement

1 Feb 2008 15:07

Marchpole Holdings PLC01 February 2008 MARCHPOLE HOLDINGS PLC ("Marchpole", "the Company" or "the Group") Interim Management Statement Marchpole Holdings plc (LSE: MPH), the fashion brand management group, has todaypublished its Interim Management Statement as required by the revised Listing Authority disclosure rules. The statement relates to the first 18 weeks of the second half of the 2007 financial year, representing the period 1 October 2007 to 31 January 2008 Our relationship with the House of Ungaro continues to develop and we have madefurther progress in establishing the Emanuel Ungaro and Ungaro Homme diffusionlabels as a worldwide menswear brand. We have restructured Moda America, oursubsidiary in the USA, which will result in significant cost savings and areduction in the losses and stabilised current trading. The Jean Charles de Castelbajac ("JCC") brand has made further progress duringthe period, and in particular, the royalty income is increasing as a result ofthe new licensing agreements that have been initiated during the last twelvemonths. In addition, we have signed the leasehold on the first UK flagship storefor the brand, which will be at 50-51 Conduit Street in the fashion heart ofLondon. We anticipate that this store will be opened by the end of spring 2008. With regard to the Ozwald Boateng range, we have settled our dispute withBespoke Couture and under the terms of the settlement we have extended ourmanufacturing and distribution license with Ozwald Boateng. As a result of thesettlement, we shall not incur any royalty payments to Bespoke Couture over thenext three years, which will result in savings of over £1 million. Sales andorders for the brand continue to grow. Greenmark Ltd, our footwear subsidiary, trades profitably and in line withexpectations. Homebody Ltd continued its development and the brand is developing its websitesales and in overseas markets. Despite the progress we have made in all areas of our business, the difficulttrading conditions in the UK and the USA have had an adverse impact on our salesand profit performance during this period. Therefore, the outturn for the yearto 31 March 2008 will result in a loss. The measures taken during the currentperiod will put the Company in a good position to increase its customer base andto take advantage of future profitable trading opportunities. We continue tofocus on seeking licensing agreements for the further expansion of our business. For further information please contact: Marchpole Holdings plcMichael Morris, Executive Deputy Chairman 020 7908 7777 Bell Pottinger Corporate & FinancialDavid Rydell / Emma Kent / Amy Rajendran 020 7861 3232 Note to Editors: - Marchpole Holdings plc ("Marchpole") is an international brand management group that designs, produces and sells clothing and accessories for ten globally recognised fashion labels. It operates in all of the world's main markets - UK, mainland Europe, Middle East, Asia and the USA - Its respected brands include Boateng, Emmanuel Ungaro, Ungaro Homme, Jean Charles de Castelbajac ("JCC"), Jean Charles de Castelbajac / Rossignol, Jean Charles de Castelbajac/Okaidi, Jean Charles de Castelbajac / New Era, JCDC/Lee Cooper and Homebody and Homemummy - Marchpole is renowned for its integrated approach to brand management, taking a brand from concept to design studio to the customer interface. - The Group has grown considerably in the past four years, from a licensee with one core licence (YSL menswear) - to today's international business that manages its brands across a multitude of clothing lines and accessories - Marchpole's acquisition (March 2006) of Moda America - the US licensee for leading designer Emanuel Ungaro - provided further growth opportunities in the UK and America and strengthened the Company's relationship with Ungaro - The acquisition also enabled the Company to launch the Ungaro brand, already established by Marchpole in Europe and Asia, into the US, Canada and South America. The acquisition has also enabled the Company to re-launch JCC into America. - In March 2007 Marchpole acquired 100% of Greenmark Limited, an importer and wholesaler of ladies shoes who currently supply in excess of 2.5 million pairs of shoes per annum. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
28th Feb 202012:00 pmRNSPositive feedback from phase 2 meeting with FDA
25th Feb 20203:00 pmRNSHolding(s) in Company
21st Feb 20202:31 pmRNSHolding(s) in Company
21st Feb 20202:30 pmRNSHolding(s) in Company
20th Feb 20204:41 pmRNSSecond Price Monitoring Extn
20th Feb 20204:36 pmRNSPrice Monitoring Extension
20th Feb 20204:06 pmRNSDirector and other PDMR Dealings
19th Feb 20208:00 amRNSEquity Investment
18th Feb 202011:00 amRNSPrice Monitoring Extension
13th Feb 202010:45 amRNSHolding(s) in Company
12th Feb 20204:00 pmRNSHolding(s) in Company
12th Feb 20201:00 pmRNSUpdate on Distribution
11th Feb 20203:00 pmRNSHolding(s) in Company
10th Feb 20202:06 pmRNSSecond Price Monitoring Extn
10th Feb 20202:00 pmRNSPrice Monitoring Extension
10th Feb 202012:00 pmRNSNovartis Financing; Purchase Agreement with Aspire
28th Jan 20202:05 pmRNSSecond Price Monitoring Extn
28th Jan 20202:00 pmRNSPrice Monitoring Extension
14th Jan 202012:00 pmRNSAdditional positive data from phase 2b study
13th Jan 20204:41 pmRNSSecond Price Monitoring Extn
13th Jan 20204:35 pmRNSPrice Monitoring Extension
13th Jan 202012:00 pmRNSMereo and Oncologie Global Licensing Agreement
6th Jan 20204:45 pmRNSHolding(s) in Company
2nd Jan 202011:05 amRNSSecond Price Monitoring Extn
2nd Jan 202011:00 amRNSPrice Monitoring Extension
31st Dec 201911:00 amRNSPrice Monitoring Extension
27th Dec 201911:05 amRNSSecond Price Monitoring Extn
27th Dec 201911:00 amRNSPrice Monitoring Extension
18th Dec 20192:22 pmRNSNotification of Major Holdings in Company
16th Dec 20192:17 pmRNSNotification of Holdings in Company
3rd Dec 20194:54 pmRNSPDMR Shareholding
27th Nov 20194:12 pmRNSDirector Shareholding
25th Nov 20195:02 pmRNSDirector Shareholding
22nd Nov 20195:09 pmRNSDirector/PDMR Shareholding
20th Nov 20192:31 pmRNSPDMR Shareholding
11th Nov 201911:05 amRNSSecond Price Monitoring Extn
11th Nov 201911:00 amRNSPrice Monitoring Extension
11th Nov 20197:00 amRNSMereo BioPharma Phase 2b ASTEROID Study
18th Oct 20197:00 amRNSHoldings in Company
17th Oct 20192:20 pmRNSHoldings in Company
14th Oct 201912:21 pmRNSNotification of Director Dealing
7th Oct 20191:00 pmRNSFDA Fast Track Designation for Navicixizumab
4th Oct 20192:57 pmRNSPDMR Notification
2nd Oct 20193:54 pmRNSPDMR Notification
26th Sep 201912:04 pmRNSPDMR Dealing
25th Sep 201910:38 amRNSPDMR Dealing
24th Sep 20191:00 pmRNSDirector Dealing
20th Sep 20192:22 pmRNSDirector Shareholding
17th Sep 20197:00 amRNSInterim results for 6 months ended June 30, 2019
13th Sep 20193:30 pmRNSDirectors' details update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.